🇺🇸 FDA
Patent

US 7132454

HEXIM1 as a suppressor of HIV replication and cardiac hypertrophy

granted A61KA61K31/16A61K31/19

Quick answer

US patent 7132454 (HEXIM1 as a suppressor of HIV replication and cardiac hypertrophy) held by The Regents of the University of California expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/16, A61K31/19, A61K31/225